| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And General Counsel | General Counsel | General Counsel
1 company
Sardano Michael is a President And General Counsel at SRTS. Recent filings cover 7 purchases and 1 sale.
Our model assigns Sardano Michael a strong insider score of 73/100, based on 8 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +47.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | SRTS Sensus Healthcare, Inc. | President And General Counsel | Buy | 1,000 | $3.80 | $3,800.00 | +0.8% | -5.2% | - | |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | President And General Counsel | Buy | 1,000 | $4.26 | $4,260.00 | +0.9% | +16.6% | - | |
| Aug 13, 2025 | SRTS Sensus Healthcare, Inc. | President And General Counsel | Buy | 1,000 | $3.37 | $3,370.00 | +0.9% | +23.1% | - | |
| Feb 10, 2025 | SRTS Sensus Healthcare, Inc. | President And General Counsel | Buy | 1,000 | $5.95 | $5,950.00 | +0.9% | -25.0% | -19.1% | |
| Aug 28, 2023 | SRTS Sensus Healthcare, Inc. | President And General Counsel | Buy | 1,000 | $2.99 | $2,990.00 | +1.7% | -14.9% | +116.3% | |
| Aug 8, 2023 | SRTS Sensus Healthcare, Inc. | President And General Counsel | Buy | 1,000 | $3.78 | $3,777.80 | +1.8% | -42.7% | +51.4% | |
| May 8, 2023 | SRTS Sensus Healthcare, Inc. | President And General Counsel | Buy | 1,000 | $3.00 | $2,995.00 | +1.8% | +15.8% | +26.8% | |
| Sep 13, 2022 | SRTS Sensus Healthcare, Inc. | President And General Counsel | Sale+OE | 5,000 | $14.13 | $70,627.50 | -9.2% | -56.4% | -80.1% |